Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 318  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed5032    
    Printed174    
    Emailed3    
    PDF Downloaded255    
    Comments [Add]    
    Cited by others 16    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2006  |  Volume : 54  |  Issue : 3  |  Page : 276--278

Intracranial hemangioblastomas: An institutional experience


Department of Neurosurgery, Neurosciences Center, All India Institute of Medical Sciences, New Delhi - 110029, India

Correspondence Address:
Bhavani Shanker Sharma
Department of Neurosurgery, Neurosciences Center, All India Institute of Medical Sciences, New Delhi - 110029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.27152

Rights and Permissions

Background and Aims: We present our Institutional experience with intracranial hemangioblastomas. Settings and Design: A retrospective study. Materials and Methods: This study included all patients of intracranial hemangioblastomas admitted in our institution over a period of 11 years from January1992 through June 2003. Results: There were a total of 69 patients (45 males and 24 females). The average age at presentation was 34.5 years. The tumor was located in the cerebellar hemispheres, vermian and brainstem regions in 42 (60%) patients, 19 (28%) patients and 8 (12%) patients, respectively. Hydrocephalus was seen in 48 (69%) patients. Thirty-three patients underwent CSF diversion procedures prior to surgery on the tumor. All except one underwent definitive surgery. The mortality was 8 (11%). Sixty eight patients underwent surgery on the tumor. The follow-up ranged from 1 month to 11 years. Fifteen patients developed recurrent lesions. Conclusion: Lifelong surveillance is necessary in cases with hemangioblastomas to identify recurrences especially in those patients having VHL syndrome.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow